Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • CDSCO mandates filing...

    CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-01T10:57:14+05:30  |  Updated On 17 Aug 2021 12:54 PM IST

    New Delhi: Through a recent notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has informed to file online applications of veterinary drugs on the new SUGAM module.


    CDSCO has initiated a comprehensive e-Governance program for filing online applications through SUGAM portal with an objective to fast track approvals and bring in complete transparency in its operations.


    "In continuation to above, a new SUGAM module for filing online applications of Veterinary Drugs has been launched on the portal," reads the notice.


    The CDSCO notice further adds that no physical application will be accepted from August 15, 2019, onwards in this regard. The drug regulatory body has directed all stakeholders to use this facility. Moreover, CDSCO shall address appropriately any suggestions to improve the services.


    Also Read: Drugs registered on SUGAM portal to be exempted from obtaining a licence for purpose of examination, test, analysis


    Implementation of e-Governance at CDSCO through SUGAM portal has brought simplicity, transparency, reliability, accountability, timeliness and also simplified ease of business. It is the project of national importance that directly reflects the Governments DIGITAL INDIA initiatives and is a major influence in bringing reforms in the Indian Pharma Industry.


    SUGAM portal provides a single-window for all its stakeholders to access the services provided by the portal by implementing role-based access control and actions. It has consolidated the entire Drug Regulatory framework at the centre and provides a centralized dashboard for monitoring the various regulatory clearances all over the country.


    SUGAM enables online submission of applications requesting for permissions related to drugs, clinical trials, ethics committee, medical devices, vaccines and cosmetics. The system also builds up the database of approved drugs, manufacturers & formulations, retailers & wholesalers in India. The project also enables the complete digitization of the old CDSCO records having primarily application within the File, noting in Green sheet, and supporting documents.


    This has enabled the provision for full text & metadata search on the scanned documents retrieval of information across multiple files for a single entity or drug type. The portal also consolidates & publishes the data about the various RCs/licenses being issued by various states Food & Drug administration offices in the country.

    CDSCOClinical TrialcosmeticsDigital Indiadrug regulatory frameworkdrugs applicationegovernanceEthics Committeefood and drugs administration officeMedical Devicesnews sugam portalonline drug applicationPharma Industrypharma newspharma news indiastakeholdersSugamsugam moduleSUGAM portalvaccines

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok